Roflumilast Tablet
Product Images NDC 67877-730

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Roflumilast (NDC 67877-730). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rof-250mcg-500s-a (Rof 250mcg 500s A)

This text provides information about Roflumilast tablets with a dosage recommendation of 250 mg for adult patients. The tablets are to be taken orally once a day for the first 28 days. The packaging details include the NDC number for identification. The text also mentions storage conditions and instructions to dispense the medication guide to each patient. The tablets are manufactured by Akem Laboratories Ltd in Mumbai, India, and distributed by Ascend Laboratories, LLC. The label specifications for the package area are also mentioned.*

FDA Label Image

Rof-250mcg-blister (Rof 250mcg Blister)

FDA Label Image

Rof-250mcg-carton-28s-b (Rof 250mcg Carton 28s B)

NDC 67877-730-93 Roflumilast Tablets 28 Day Pack. Each tablet contains 250 mcg roflumilast. The recommended starting dose for adults is one tablet (250 mcg) by mouth once a day for the first 28 days. Store at 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (59°F to 86°F). Warning: Do not remove from blister package until immediately prior to administration. Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, INDIA. Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.*

FDA Label Image

Rof01 (Rof01)

FDA Label Image

Rof02 (Rof02)

This is not available.*

FDA Label Image

Rof03mcg-new-b (Rof03mcg New B)

FDA Label Image

Rof06-new-a (Rof06 New A)

This text appears to be a medication label providing information such as dosage instructions, storage conditions, manufacturer details, and contact information for distribution. It mentions that each tablet contains 500mg of the active ingredient and recommends taking one tablet per day for adults. The medication is distributed by Ascond Laboratories, with manufacturing by Ao Laboratories in India. It also includes a note to dispense the accompanying Medication Guide to each patient. Additionally, the text includes details about temperature storage recommendations and the size of the tablet pack.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.